The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...

ANAHEIM, Calif., July 25, 2023 /PRNewswire/ -- Fapon, a global leading life sciences company, has announced the launch of its latest chemiluminescence immunoassay system Shine i8000/9000 to global ...

According to SNS Insider, the Chemiluminescence Immunoassay (CLIA) Market was valued at USD 11.76 billion in 2023 and is projected to reach USD 17.72 billion by 2032, growing at a CAGR of 4.68% ...

SAN DIEGO, March 14, 2017 /PRNewswire/ -- Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical lab ...

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Chemiluminescence Immunoassay Analyzers - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for ...

CHICAGO, July 5, 2023 /PRNewswire/ -- In the near future, the chemiluminescence immunoassay industry is set to witness remarkable advancements, revolutionizing diagnostics and research in various ...

The study on chemiluminescence immunoassay analyzers market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

Chemiluminescent Enzyme Immunoassay (CLEIA) represents a breakthrough in diagnostics, combining the unparalleled sensitivity of chemiluminescence and distinctive specificity.

“Unquantifiably Low Aldosterone Concentrations Are Prevalent in Hospitalised COVID-19 Patients but May Not Be Revealed by Chemiluminescent Immunoassay.” Endocrine Connections 11 (11). https ...